|
XYLB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.415190E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.024800E-04 |
| Normal-vs-Stage2 |
4.721300E-03 |
| Normal-vs-Stage3 |
1.578600E-04 |
| Normal-vs-Stage4 |
2.357400E-04 |
| Stage1-vs-Stage2 |
8.888600E-01 |
| Stage1-vs-Stage3 |
7.745400E-01 |
| Stage1-vs-Stage4 |
5.058600E-01 |
| Stage2-vs-Stage3 |
7.762200E-01 |
| Stage2-vs-Stage4 |
4.901200E-01 |
| Stage3-vs-Stage4 |
4.020600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.395700E-04 |
| Normal-vs-AfricanAmerican |
1.58542999999511E-05 |
| Normal-vs-Asian |
1.207860E-04 |
| Caucasian-vs-AfricanAmerican |
3.905000E-03 |
| Caucasian-vs-Asian |
3.746000E-01 |
| AfricanAmerican-vs-Asian |
8.334200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.003870E-04 |
| Normal-vs-Female |
6.585800E-04 |
| Male-vs-Female |
3.017400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.36320000000157E-05 |
| Normal-vs-Extreme_Weight |
3.91510000000705E-05 |
| Normal-vs-Obese |
1.205090E-04 |
| Normal-vs-Extreme_Obese |
4.723000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.416400E-01 |
| Normal_Weight-vs-Obese |
6.175000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.922600E-01 |
| Extreme_Weight-vs-Obese |
5.463400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.868610E-01 |
| Obese-vs-Extreme_Obese |
2.308400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.642440E-02 |
| Normal-vs-Age(41-60Yrs) |
5.87789999999533E-05 |
| Normal-vs-Age(61-80Yrs) |
2.399200E-04 |
| Normal-vs-Age(81-100Yrs) |
1.050310E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.437200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.242400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.394800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.943000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.651760E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.636800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.29779999999713E-05 |
| Normal-VS-Type2 PRCC |
2.300900E-03 |
| Normal-VS-KIRP CIMP |
1.91827999999061E-05 |
| Normal-VS-Unclassified PRCC |
6.439400E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.801860E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.948800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.498200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.657500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.269400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.339620E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.039790E-03 |
| Normal-vs-N1 |
5.603800E-04 |
| Normal-vs-N2 |
1.34340000002009E-06 |
| N0-vs-N1 |
7.767800E-01 |
| N0-vs-N2 |
5.198200E-03 |
| N1-vs-N2 |
1.819990E-01 |
|
|
